SAGE Cardiology and Cardiovascular Medicine
9min2020 MAR 11
播放聲音
喜歡
評論
分享

詳細信息

The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, gender, prematurity, weight, cardiopulmonary bypass times, and cross-clamp times. Fifty-nine cases were individually matched to 59 controls based on propensity scores. 3FPCC was not associated with an increased risk of thromboembolic events, mortality, or need for postoperative extracorporeal membrane oxygenator support. These results suggest the safety of 3FPCC when used for refractory bleeding after cardiopulmonary bypass in children undergoing congenital heart surgery. To view the article,click here.

查看更多

SCVA COVID-19 Podcast Part 2

19min

SCVA COVID-19 Podcast Part 1

23min

SCVA March 2020 Podcast: A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study

9min

SCVA July 2019 Podcast: Congenital Cardiac Anesthesia Society Meeting Abstracts

12min

SCVA June 2019 Podcast: Noteworthy Literature in 2018 for Cardiovascular Anesthesiologists and Intensivists

14min

SCVA April 2018 Podcast: Society for the Advancement of Transplant Anesthesia: Liver Transplant Anesthesia Fellowship—White Paper Advocating Measurable Proficiency in Transplant Specialties Training

13min

SCVA June 2017 Podcast: Occupational Radiation Exposure of Anesthesia Providers

12min

SCVA March 2017 Podcast: Noteworthy Literature Published in 2016 for Abdominal Organ Transplantation Anesthesiologists: Liver

20min